Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05624203

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05624203
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05624203. Randomized; no masking; primary purpose treatment. Start 2022-12-01 (anticipated); primary completion 2024-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Efficacy of Extracorporeal Cardiac Shock Wave Therapy in Patients With Ischemia-reperfusion Injury
Acronym
CEECSWIRI
Condition
Myocardial Reperfusion Injury
Condition
Treatment Outcome
Condition
Prognosis
Condition
ST Elevation Myocardial Infarction
Intervention (Device)
Extracorporeal cardiac shock wave therapy(ECSW)
Lead sponsor
First Affiliated Hospital of Kunming Medical University (class: other)

Record details

Record id
cardio:ct-nct05624203
Content hash
335bf80463b4b9ce52d4517be930b094fe08b4990f7ad86ee9423461299fc2dd